5 reports

DEMAND FOR COMPACT, LIGHTWEIGHT PORTABLE NEBULIZERS IS BEING DRIVEN BY THE ACTIVE LIFESTYLES OF CHILDREN WITH ASTHMA AND SENIORS WITH COPD WITH ANALYSTS ESTIMATING THE GLOBAL PULMONARY DRUG DELIVERY TECHNOLOGIES MARKET TO GROW BETWEEN ##% AND ##% IN THE COMING PERIOD. ## Appendix THE DATA AND

  • Angio Suite
  • Europe
  • Italy
  • Market Size
  • GE Healthcare Limited

According to the AHA, antiplatelet therapy is not recommended for patients with a history of asthma, bleeding disorders, gastrointestinal disease, high blood pressure, liver and kidney disease, and peptic ulcers; patients with a history of the aforementioned conditions may require special d

  • Angio Suite
  • United States
  • Forecast
  • GE Healthcare Limited
  • Stryker Corporation

DISTINGUISHING THE GROUP OF ASTHMA AN D COPD PATIENTS FROM THE NO RESPIRATORY DISEASE GROUP WAS ALSO ACHIEVED AT AN ACCURACY OF ## %.

  • Angio Suite
  • Medical Device
  • Canada
  • North America
  • Market Size

DISTINGUISHING THE GROUP OF ASTHMA AN D COPD PATIENTS FROM THE NO RESPIRATORY DISEASE GROUP WAS ALSO ACHIEVED AT AN ACCURACY OF ## %.

  • Angio Suite
  • Contrast Media Injector
  • Australia
  • Oceania
  • Market Size

Clinical studies that started at the beginning of the year with the asthma product Ventica®continue in Croatia, Germany, and Finland.

  • Angio Suite
  • Clinical Trial
  • Eyewear
  • United States
  • GlobalData's company